The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger, KS Corbett… - Science translational …, 2021 - science.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

[HTML][HTML] The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger… - Science Translational …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger… - Science …, 2021 - researchexperts.utmb.edu
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

[PDF][PDF] The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

2021 - scienceopen.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger, KS Corbett… - Science Translational …, 2021 - osti.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

BE Jones, PL Brown-Augsburger… - Science Translational …, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

[引用][C] The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger, KS Corbett… - Science Translational …, 2021 - cir.nii.ac.jp
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman
primates | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

BE Jones, PL Brown-Augsburger… - Science …, 2021 - search.ebscohost.com
A monoclonal for SARS-CoV-2: Among the most promising therapeutic options for
individuals with coronavirus disease 2019 (COVID-19) are monoclonal antibodies (mAbs) …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

BE Jones, PL Brown-Augsburger… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

BE Jones, PL Brown-Augsburger… - Science Translational …, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health
threat for which preventive and therapeutic agents are urgently needed. Neutralizing …